Spray- and laser-assisted biomaterial processing for fast and efficient autologous cell-plus-matrix tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 12, 2015, Pages E177-E190

  Klopsch, Christian ^a   Gäbel, Ralf ^a   Kaminski, Alexander ^a   Mark, Peter ^a   Wang, Weiwei ^a,d   Toelk, Anita ^a   Delyagina, Evgenya ^a   Kleiner, Gabriela ^a   Koch, Lothar ^b   Chichkov, Boris ^b   Mela, Petra ^c   Jockenhoevel, Stefan ^c   Ma, Nan ^a,d   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LASER ZENTRUM HANNOVER E V   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Cell printing; Heart valve; Intraoperative table side tissue engineering; Laser induced forward transfer; Sprayed cell seeding; Stem cell plus fibrin coating

Indexed keywords

CELL CULTURE; CELL ENGINEERING; COATINGS; ENDOTHELIAL CELLS; SCAFFOLDS (BIOLOGY); TISSUE;

CELL PRINTING; CELL SEEDING; HEART VALVES; INTRA-OPERATIVE; INTRAOPERATIVE TABLE-SIDE TISSUE ENGINEERING; LASER-INDUCED FORWARD TRANSFER; SPRAYED CELL SEEDING; STEM CELL-PLUS-FIBRIN COATING; STEM-CELL; TISSUES ENGINEERINGS;

STEM CELLS;

BIOMATERIAL; FIBRIN; POLYCAPROLACTONE; POLYESTER;

ARTICLE; BIOPRINTING; BIOPROCESS; BIOREACTOR; CELL DENSITY; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROSPINNING; ENGRAFTMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LASER ASSISTED BIOPROCESSING; MATERIAL COATING; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SPRAY ASSISTED BIOPROCESSING; STRUCTURE ANALYSIS; TISSUE ENGINEERING; TISSUE SCAFFOLD; UMBILICAL VEIN ENDOTHELIAL CELL; CHEMISTRY; CYTOLOGY; FEMALE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES;

EXTRACELLULAR MATRIX; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; POLYESTERS; TISSUE ENGINEERING;

EID: 84955188572     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1657     Document Type: Article

References (58)

1. Baker BM, Nerurkar NL, Burdick JA, et al. 2009; Fabrication and modeling of dynamic multipolymer nanofibrous scaffolds. J Biomech Eng 131: 101012.
2. Bölgen N, Menceloğlu YZ, Acatay K, et al. 2005; In vitro and in vivo degradation of non-woven materials made of poly(ε-caprolactone) nanofibers prepared by electrospinning under different conditions. J Biomater Sci Polym Ed 16: 1537-1555.
3. Brown JW, Ruzmetov M, Rodefeld MD, et al. 2005; Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 80: 655-663.
4. Butcher JT, Tressel S, Johnson T, et al. 2006; Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol 26: 69-77.
5. Cannegieter SC, Rosendaal FR, Briet E. 1994; Thromboembolic and bleeding complications in patients with mechanical heart valve prosthesis. Circulation 89: 635-641.
6. Cholewinski E, Dietrich M, Flanagan TC, et al. 2009; Tranexamic acid - an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 15: 3645-3653.
7. Chomczynski P, Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
8. Crawley JT, Lane DA. 2008; The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 28: 233-242.
9. Del Gaudio C, Bianco A, Grigioni M. 2008; Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design. Ann Ist Super Sanita 44: 178-186.
10. Eshraghi S, Das S. 2010; Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sintering. Acta Biomater 6: 2467-2476.
11. Flanagan TC, Cornelissen C, Koch S, et al. 2007; The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28: 3388-3397.
12. Flanagan TC, Sachweh JS, Frese J, et al. 2009; In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15: 2965-2976.
13. Flemming RG, Murphy CJ, Abrams GA, et al. 1999; Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 20: 573-588.
14. Frigiola A, Varrica A, Satriano A, et al., Surgical and Clinical Outcome REsearch (SCORE) Group. 2010; Neoaortic valve and root complex evolution after Ross operation in infants, children, and adolescents. Ann Thorac Surg 90: 1278-1285.
15. Gaebel R, Furlani D, Sorg H, et al. 2011a; CD105 expression on human mesenchymal stem cells depends on cell origin and determines a different healing performance in cardiac regeneration. PLoS One 6: e15652.
16. Gaebel R, Ma N, Liu J, et al. 2011b; Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials 32: 9218-9230.
17. Gaumer J, Prasad A, Lee D, et al. 2009; Structure-function relationships and source-to-ground distance in electrospun polycaprolactone. Acta Biomater 5: 1552-1561.
18. Ghasemi-Mobarakeh L, Morshed M, Karbalaie K, et al. 2009; The thickness of electrospun poly(ε-caprolactone) nanofibrous scaffolds influences cell proliferation. Int J Artif Organs 32: 150-158.
19. Grant I, Warwick K, Marshall J, et al. 2002; The co-application of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model. Br J Plast Surg 55: 219-227.
20. Griese DP, Ehsan A, Melo LG, et al. 2003; Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108: 2710-2715.
21. Gruene M, Deiwick A, Koch L, et al. 2010; Laser printing of stem cells for biofabrication of scaffold-free autologous grafts. Tissue Eng Part C Methods 17: 79-87.
22. Gruene M, Pflaum M, Hess C, et al. 2011; Laser printing of three-dimensional multicellular arrays for studies of cell-cell and cell-environment interactions. Tissue Eng Part C Methods 17: 973-982.
23. Hammermeister KE, Sethi GK, Henderson WG, et al. 1993; A comparison of outcomes in men 11years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 328: 1289-1296.
24. Horvath KA, Berry GJ, ICEM Investigators. 2005; The incidence of emboli during cardiac surgery: a histopathologic analysis of 2297 patients. Heart Surg Forum 8: E161-166.
25. Jockenhoevel S, Zund G, Hoerstrup SP, et al. 2001; Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19: 424-430.
26. + stem cell-plus-fibrin composite based sprayed cell seeding for intra-operative heart valve tissue engineering. Tissue Eng C 17: 299-309.
27. Kern S, Eichler H, Stoeve J, et al. 2006; Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
28. Klopsch C, Donndorf P, Kaminski A, et al. 2011; Cell sources for cardiovascular tissue engineering. Chirurgie 82: 295-302.
29. Klopsch C, Steinhoff G. 2012; Tissue-engineered devices in cardiovascular surgery. Eur Surg Res 49: 44-52.
30. Koch L, Kuhn S, Sorg H, et al. 2010a; Laser printing of skin cells and human stem cells. Tissue Eng Part C Methods 16: 847-854.
31. Koch S, Flanagan TC, Sachweh JS, et al. 2010b; Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 31: 4731-4739.
32. Koolwijk P, van Erck MG, de Vree WJ, et al. 1996; Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132: 1177-1188.
33. Lebourg M, Sabater Serra R, Más Estellés J, et al. 2008; Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique. J Mater Sci Mater Med 19: 2047-2053.
34. Lopez-Vilchez I, Tonda R, Hernandez RM, et al. 2009; Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in vitro studies with circulating blood. Coron Artery Dis 20: 392-399.
35. Mayer JE Jr. 2001; In search of the ideal valve replacement device. J Thorac Cardiovasc Surg 122: 8-9.
36. Nehls V, Schuchardt E, Drenckhahn D. 1994; The effect of fibroblasts, vascular smooth muscle cells, and pericytes on sprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvasc Res 48: 349-363.
37. Nottelet B, Pektok E, Mandracchia D, et al. 2009; Factorial design optimization and in vivo feasibility of poly(ε-caprolactone) micro- and nanofiber-based small diameter vascular grafts. J Biomed Mater Res A 89: 865-875.
38. Pektok E, Nottelet B, Tille JC, et al. 2008; Degradation and healing characteristics of small-diameter poly(ε-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118: 2563-2570.
39. Peroglio M, Gremillard L, Gauthier C, et al. 2010; Mechanical properties and cytocompatibility of poly(ε-caprolactone)-infiltrated biphasic calcium phosphate scaffolds with bimodal pore distribution. Acta Biomater 6: 4369-4379.
40. Pörtner R, Nagel-Heyer S, Goepfert C, et al. 2005; Bioreactor design for tissue engineering. J Biosci Bioeng 100: 235-245.
41. Rabkin-Aikawa E, Farber M, Aikawa M, et al. 2004; Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 13: 841-847.
42. Rajani B, Mee RB, Ratliff NB. 1998; Evidence for rejection of homograft cardiac heart valves in infants. J Thorac Cardiovasc Surg 115: 111-117.
43. Riepe G, Chakfé N, Meincke J, et al. 2001; Late complications after alloplastic vascular replacement. Kongressbd Dtsch Ges Chir Kongr 118: 475-477.
44. Rozemuller H, Prins HJ, Naaijkens B, et al. 2010; Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies. Stem Cells 19: 1911-1921.
45. Rüffer A, Purbojo A, Cicha I, et al. 2010; Early failure of xenogenous de-cellularised pulmonary valve conduits - a word of caution! Eur J Cardiothorac Surg 38: 78-85.
46. Sant S, Khademhosseini A. 2010; Fabrication and characterization of tough elastomeric fibrous scaffolds for tissue engineering applications. Conf Proc IEEE Eng Med Biol Soc 2010: 3546-3548.
47. Sarkar S, Isenberg BC, Hodis E, et al. 2008; Fabrication of a layered microstructured polycaprolactone construct for 3D tissue engineering. J Biomater Sci Polym Ed 19: 1347-1362.
48. Serrano MC, Portolés MT, Vallet-Regí M, et al. 2005; Vascular endothelial and smooth muscle cell culture on NaOH-treated poly(ε-caprolactone) films: a preliminary study for vascular graft development. Macromol Biosci 5: 415-423.
49. Sodian R, Hoerstrup SP, Sperling JS, et al. 2000; Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102: III22-29.
50. Soliman S, Sant S, Nichol JW, et al. 2011; Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A 96: 566-574.
51. Steinhoff G, Stock U, Karim N, et al. 2000; Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102: III50-55.
52. Syedain ZH, Weinberg JS, Tranquillo RT. 2008; Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci USA 105: 6537-6542.
53. Tan PH, Chan C, Xue SA, et al. 2004; Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis 173: 171-183.
54. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. 1996; Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94: 1690-1697.
55. Vesely I. 2005; Heart valve tissue engineering. Circ Res 97: 743-755.
56. Wang S, Yaszemski MJ, Gruetzmacher JA, et al. 2008; Photo-crosslinked poly(ε-caprolactone fumarate) networks: roles of crystallinity and crosslinking density in determining mechanical properties. Polymer (Guildf) 49: 5692-5699.
57. Ward MR, Stewart DJ. 2008; Erythropoietin and mesenchymal stromal cells in angiogenesis and myocardial regeneration: one plus one equals three? Cardiovasc Res 79: 357-359.
58. Wulf K, Teske M, Löbler M, et al. 2011; Surface functionalization of poly(ε-caprolactone) improves its biocompatibility as scaffold material for bioartificial vessel prostheses. J Biomed Mater Res B Appl Biomater 98: 89-100.